LRP-5

LRP-5 Overview

English NameLow-density lipoprotein receptor-related protein 5Approved Drugs0
Drugs in Clinical Trials2Target Synonym
Highest Development StagePhase 3 Clinical
English NameLow-density lipoprotein receptor-related protein 5
Target Synonym
Approved Drugs0
Drugs in Clinical Trials2
Highest Development StagePhase 3 Clinical

LRP-5 Product List

  • Product Category

    Protein (1)

  • Product Status

    Launched (1)

  • Species

    Human (1)

  • Tag

    His Tag & Avi Tag (1)

  • Conjugate

    Biotin-labeled (1)

Cat. No.SpeciesHostProduct DescriptionStructurePurityFeature
LR5-H82E6
Human
HEK293
Biotinylated Human LRP-5 Protein, His,Avitag™
Total: 1
  • 1

LRP-5 Background

Low-density lipoprotein receptor-related protein 5(LRP-5) is also known as BMND1, EVR1, EVR4, HBM, LR3, LRP7, OPPG, OPTA1, VBCH2, LDL receptor related protein 5 and PCLD4. LRP5 is a transmembrane low-density lipoprotein receptor that shares a similar structure with LRP6. LRP5 acts as a co-receptor with LRP6 and the Frizzled protein family members for transducing signals by Wnt proteins through the canonical Wnt pathway. This protein plays a key role in skeletal homeostasis. Mutations in LRP5 can lead to considerable changes in bone mass. A loss-of-function mutation causes osteoporosis-pseudoglioma (decrease in bone mass), while a gain-of-function mutation causes drastic increases in bone mass.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
RestoretEYE103; EYE-103; MK-3000; ANT-39Phase 3 ClinicalEyebiotech LtdDiabetic macular oedema; Macular Degeneration; Retinal Vein Occlusion
Details
BI-905681BI-905681Phase 1 ClinicalBoehringer Ingelheim LtdNeoplasms
Details
  • Overview
  • Product List
  • Clinical Drug Information